165 related articles for article (PubMed ID: 30168015)
1. Plasma HIV RNA level is associated with neurocognitive function among HIV-1-infected patients in Nigeria.
Jumare J; El-Kamary SS; Magder L; Hungerford L; Ndembi N; Aliyu A; Dakum P; Umlauf A; Cherner M; Abimiku A; Charurat M; Blattner WA; Royal W
J Neurovirol; 2018 Dec; 24(6):712-719. PubMed ID: 30168015
[TBL] [Abstract][Full Text] [Related]
2. Peripheral blood lymphocyte HIV DNA levels correlate with HIV associated neurocognitive disorders in Nigeria.
Jumare J; Sunshine S; Ahmed H; El-Kamary SS; Magder L; Hungerford L; Burdo T; Eyzaguirre LM; Umlauf A; Cherner M; Abimiku A; Charurat M; Li JZ; Blattner WA; Royal W
J Neurovirol; 2017 Jun; 23(3):474-482. PubMed ID: 28243867
[TBL] [Abstract][Full Text] [Related]
3. Cognitive Function Among Antiretroviral Treatment-Naive Individuals Infected With Human Immunodeficiency Virus Type 1 Subtype G Versus CRF02_AG in Nigeria.
Jumare J; Ndembi N; El-Kamary SS; Magder L; Hungerford L; Burdo T; Eyzaguirre LM; Dakum P; Umlauf A; Cherner M; Abimiku A; Charurat M; Blattner WA; Royal W
Clin Infect Dis; 2018 Apr; 66(9):1448-1453. PubMed ID: 29182762
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of HIV RNA and markers of immune activation as predictors of HIV-associated dementia.
Sevigny JJ; Albert SM; McDermott MP; McArthur JC; Sacktor N; Conant K; Schifitto G; Selnes OA; Stern Y; McClernon DR; Palumbo D; Kieburtz K; Riggs G; Cohen B; Epstein LG; Marder K
Neurology; 2004 Dec; 63(11):2084-90. PubMed ID: 15596754
[TBL] [Abstract][Full Text] [Related]
5. Elevated Plasma Levels of sCD14 and MCP-1 Are Associated With HIV Associated Neurocognitive Disorders Among Antiretroviral-Naive Individuals in Nigeria.
Jumare J; Akolo C; Ndembi N; Bwala S; Alabi P; Okwuasaba K; Adebiyi R; Umlauf A; Cherner M; Abimiku A; Charurat M; Blattner WA; Royal W
J Acquir Immune Defic Syndr; 2020 Jun; 84(2):196-202. PubMed ID: 32084055
[TBL] [Abstract][Full Text] [Related]
6. Neurocognitive impairment associated with predominantly early stage HIV infection in Abuja, Nigeria.
Akolo C; Royal W; Cherner M; Okwuasaba K; Eyzaguirre L; Adebiyi R; Umlauf A; Hendrix T; Johnson J; Abimiku A; Blattner WA
J Neurovirol; 2014 Aug; 20(4):380-7. PubMed ID: 24927825
[TBL] [Abstract][Full Text] [Related]
7. HIV DNA and cognition in a Thai longitudinal HAART initiation cohort: the SEARCH 001 Cohort Study.
Valcour VG; Shiramizu BT; Sithinamsuwan P; Nidhinandana S; Ratto-Kim S; Ananworanich J; Siangphoe U; Kim JH; de Souza M; Degruttola V; Paul RH; Shikuma CM;
Neurology; 2009 Mar; 72(11):992-8. PubMed ID: 19289739
[TBL] [Abstract][Full Text] [Related]
8. Determining optimal impairment rating methodology for a new HIV-associated neurocognitive disorder screening procedure.
Kamminga J; Bloch M; Vincent T; Carberry A; Brew BJ; Cysique LA
J Clin Exp Neuropsychol; 2017 Oct; 39(8):753-767. PubMed ID: 28052738
[TBL] [Abstract][Full Text] [Related]
9. Associations between Cognition, Gender and Monocyte Activation among HIV Infected Individuals in Nigeria.
Royal W; Cherner M; Burdo TH; Umlauf A; Letendre SL; Jumare J; Abimiku A; Alabi P; Alkali N; Bwala S; Okwuasaba K; Eyzaguirre LM; Akolo C; Guo M; Williams KC; Blattner WA
PLoS One; 2016; 11(2):e0147182. PubMed ID: 26829391
[TBL] [Abstract][Full Text] [Related]
10. Neuropsychological outcomes in adults commencing highly active anti-retroviral treatment in South Africa: a prospective study.
Joska JA; Westgarth-Taylor J; Hoare J; Thomas KG; Paul R; Myer L; Stein DJ
BMC Infect Dis; 2012 Feb; 12():39. PubMed ID: 22335937
[TBL] [Abstract][Full Text] [Related]
11. Cerebrospinal fluid cell-free mitochondrial DNA is associated with HIV replication, iron transport, and mild HIV-associated neurocognitive impairment.
Mehta SR; Pérez-Santiago J; Hulgan T; Day TR; Barnholtz-Sloan J; Gittleman H; Letendre S; Ellis R; Heaton R; Patton S; Suben JD; Franklin D; Rosario D; Clifford DB; Collier AC; Marra CM; Gelman BB; McArthur J; McCutchan A; Morgello S; Simpson D; Connor J; Grant I; Kallianpur A
J Neuroinflammation; 2017 Mar; 14(1):72. PubMed ID: 28359324
[TBL] [Abstract][Full Text] [Related]
12. Randomized double-blind placebo-controlled trial of peptide T for HIV-associated cognitive impairment.
Heseltine PN; Goodkin K; Atkinson JH; Vitiello B; Rochon J; Heaton RK; Eaton EM; Wilkie FL; Sobel E; Brown SJ; Feaster D; Schneider L; Goldschmidts WL; Stover ES
Arch Neurol; 1998 Jan; 55(1):41-51. PubMed ID: 9443710
[TBL] [Abstract][Full Text] [Related]
13. Factors influencing cerebrospinal fluid and plasma HIV-1 RNA detection rate in patients with and without opportunistic neurological disease during the HAART era.
Christo PP; Greco DB; Aleixo AW; Livramento JA
BMC Infect Dis; 2007 Dec; 7():147. PubMed ID: 18096083
[TBL] [Abstract][Full Text] [Related]
14. Antiretroviral monocyte efficacy score linked to cognitive impairment in HIV.
Shikuma CM; Nakamoto B; Shiramizu B; Liang CY; DeGruttola V; Bennett K; Paul R; Kallianpur K; Chow D; Gavegnano C; Hurwitz SJ; Schinazi RF; Valcour VG
Antivir Ther; 2012; 17(7):1233-42. PubMed ID: 23018140
[TBL] [Abstract][Full Text] [Related]
15. Regional areas and widths of the midsagittal corpus callosum among HIV-infected patients on stable antiretroviral therapies.
Tate DF; Sampat M; Harezlak J; Fiecas M; Hogan J; Dewey J; McCaffrey D; Branson D; Russell T; Conley J; Taylor M; Schifitto G; Zhong J; Daar ES; Alger J; Brown M; Singer E; Campbell T; McMahon D; Tso Y; Matesan J; Letendre S; Paulose S; Gaugh M; Tripoli C; Yiannoutsos C; Bigler ED; Cohen RA; Guttmann CR; Navia B;
J Neurovirol; 2011 Aug; 17(4):368-79. PubMed ID: 21556960
[TBL] [Abstract][Full Text] [Related]
16. Clinical factors related to brain structure in HIV: the CHARTER study.
Jernigan TL; Archibald SL; Fennema-Notestine C; Taylor MJ; Theilmann RJ; Julaton MD; Notestine RJ; Wolfson T; Letendre SL; Ellis RJ; Heaton RK; Gamst AC; Franklin DR; Clifford DB; Collier AC; Gelman BB; Marra C; McArthur JC; McCutchan JA; Morgello S; Simpson DM; Grant I;
J Neurovirol; 2011 Jun; 17(3):248-57. PubMed ID: 21544705
[TBL] [Abstract][Full Text] [Related]
17. Mitochondrial DNA Haplogroups and Neurocognitive Impairment During HIV Infection.
Hulgan T; Samuels DC; Bush W; Ellis RJ; Letendre SL; Heaton RK; Franklin DR; Straub P; Murdock DG; Clifford DB; Collier AC; Gelman BB; Marra CM; McArthur JC; McCutchan JA; Morgello S; Simpson DM; Grant I; Kallianpur AR;
Clin Infect Dis; 2015 Nov; 61(9):1476-84. PubMed ID: 26129753
[TBL] [Abstract][Full Text] [Related]
18. Plasma sCD14 is a biomarker associated with impaired neurocognitive test performance in attention and learning domains in HIV infection.
Lyons JL; Uno H; Ancuta P; Kamat A; Moore DJ; Singer EJ; Morgello S; Gabuzda D
J Acquir Immune Defic Syndr; 2011 Aug; 57(5):371-9. PubMed ID: 21646912
[TBL] [Abstract][Full Text] [Related]
19. The incidence of and risk factors for HIV-associated cognitive-motor complex among patients on HAART.
Jevtović Dj; Vanovac V; Veselinović M; Salemović D; Ranin J; Stefanova E
Biomed Pharmacother; 2009 Sep; 63(8):561-5. PubMed ID: 19026516
[TBL] [Abstract][Full Text] [Related]
20. Plasma viral load and CD4 lymphocytes predict HIV-associated dementia and sensory neuropathy.
Childs EA; Lyles RH; Selnes OA; Chen B; Miller EN; Cohen BA; Becker JT; Mellors J; McArthur JC
Neurology; 1999 Feb; 52(3):607-13. PubMed ID: 10025796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
